Yesterday it was reported that a Director at R1 RCM Inc (RCM), Charles Ditkoff, exercised options to sell 4,099 RCM shares for a total transaction value of $48.04K.
Following Charles Ditkoff’s last RCM Sell transaction on November 19, 2018, the stock climbed by 3.9%.
See today’s analyst top recommended stocks >>
Based on R1 RCM Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $276 million and quarterly net profit of $200K. In comparison, last year the company earned revenue of $147 million and had a GAAP net loss of $23.3 million. The Company has a Price to Book ratio of 349.8839. Currently, R1 RCM Inc has an average volume of 1.45M.
One of the top 25 analysts, according to TipRanks.com, recently recommended Buy RCM with a $14 price target.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.
